Anders Sundan

10.3k total citations · 1 hit paper
160 papers, 8.2k citations indexed

About

Anders Sundan is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Anders Sundan has authored 160 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 76 papers in Hematology and 57 papers in Immunology. Recurrent topics in Anders Sundan's work include Multiple Myeloma Research and Treatments (72 papers), Immune Response and Inflammation (26 papers) and Liver physiology and pathology (21 papers). Anders Sundan is often cited by papers focused on Multiple Myeloma Research and Treatments (72 papers), Immune Response and Inflammation (26 papers) and Liver physiology and pathology (21 papers). Anders Sundan collaborates with scholars based in Norway, United States and Denmark. Anders Sundan's co-authors include Magne Børset, Terje Espevik, Anders Waage, Carina Seidel, Therese Standal, Henrik Hjorth‐Hansen, Egil Lien, Toril Holien, Liv Ryan and Øyvind Hjertner and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Anders Sundan

156 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Soluble CD14 participates in the response of cells to lipopolysaccharide.

1992 591 citations Anders Sundan, Terje Espevik et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Anders Sundan

Since Specialization

Citations

This map shows the geographic impact of Anders Sundan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Sundan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Sundan more than expected).

Fields of papers citing papers by Anders Sundan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Sundan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Sundan. The network helps show where Anders Sundan may publish in the future.

Co-authorship network of co-authors of Anders Sundan

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Sundan. A scholar is included among the top collaborators of Anders Sundan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Sundan. Anders Sundan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone 2025 ·eJHaem ·Tobias S. Slørdahl, (unknown), (unknown), (unknown), (unknown), (unknown), Nils Tore Vethe, Henrik Hjorth‐Hansen, Mona Høysæter Fenstad, Anders Waage, Øyvind Hjertner, Fredrik Schjesvold, Anders Sundan	0
2	Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence 2022 ·Leukemia ·Kristine Misund, Davine Hofste op Bruinink, Eivind Coward, Remco M. Hoogenboezem, Even H Rustad, Mathijs A. Sanders, Morten Beck Rye, Anne‐Marit Sponaas, Bronno van der Holt, Sonja Zweegman, Eivind Hovig, Leonardo A. Meza‐Zepeda, Anders Sundan, Ola Myklebost, Pieter Sonneveld, Anders Waage	34
3	TGF-β contamination of purified recombinant GDF15 2017 ·PLoS ONE ·Oddrun Elise Olsen, (unknown), Berit Størdal, Anders Sundan, Toril Holien	68
4	Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro 2016 ·Journal of Hematology & Oncology ·Thea Kristin Våtsveen, Anne‐Marit Sponaas, Erming Tian, Qing Zhang, Kristine Misund, Anders Sundan, Magne Børset, Anders Waage, Gaute Brede	10
5	The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2 2015 ·Biomacromolecules ·Øystein Arlov, Finn L. Aachmann, Emadoldin Feyzi, Anders Sundan, Gudmund Skjåk‐Bræk	27
6	Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B 2015 ·Cell Communication and Signaling ·Oddrun Elise Olsen, Karin Fahl Wader, Hanne Hella, Anne K. Mylin, Ingemar Turesson, Ingerid Nesthus, Anders Waage, Anders Sundan, Toril Holien	124
7	A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells 2013 ·SLAS DISCOVERY ·Kristine Misund, Katarzyna Anna Baranowska, Toril Holien, (unknown), Dionne C.G. Klein, Magne Børset, Anders Waage, Anders Sundan	21
8	Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway 2013 ·Cancer Letters ·(unknown), Maria Lyngaas Torgersen, (unknown), Kristine Misund, Anders Sundan, Heidi Kiil Blomhoff	28
9	Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis 2010 ·Arthritis & Rheumatism ·(unknown), Silje Watterdal Syversen, Mari Hoff, Anders Sundan, Glenn Haugeberg, Désirée van der Heijde, Tore K Kvien, Therese Standal	28
10	High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis 2009 ·European Journal Of Haematology ·Anne‐Tove Brenne, Unn‐Merete Fagerli, John D. Shaughnessy, Thea Kristin Våtsveen, Torstein B. Rø, Hanne Hella, Fenghuang Zhan, Bart Barlogie, Anders Sundan, Magne Børset, Anders Waage	34
11	Hepatocyte growth factor promotes migration of human myeloma cells 2008 ·Haematologica ·Randi Utne Holt, Unn‐Merete Fagerli, Vadim Baykov, Torstein B. Rø, (unknown), Anders Waage, Anders Sundan, Magne Børset	35
12	Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma 2008 ·European Journal Of Haematology ·Karin Fahl Wader, Unn‐Merete Fagerli, Randi Utne Holt, Berit Størdal, Magne Børset, Anders Sundan, Anders Waage	30
13	Toll-like receptors mediate proliferation and survival of multiple myeloma cells 2006 ·Leukemia ·Janne Ø. Bohnhorst, T. Rasmussen, Siv Helen Moen, (unknown), Lene Meldgaard Knudsen, Magne Børset, Terje Espevik, Anders Sundan	124
14	Low serum levels of soluble tumor necrosis factor receptors predict for response to thalidomide in advanced myeloma. 2002 ·Blood ·Anders Waage, (unknown), (unknown), Peter Gimsing, Gunnar Juliusson, Ingela Turesson, Magne Børset, Anders Sundan	2
15	Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA 2002 ·Journal of Immunological Methods ·Nina‐Beate Liabakk, Anders Sundan, Sverre H. Torp, Pål Aukrust, Stig S. Frøland, Terje Espevik	43
16	Human Toll-Like Receptor 2 Mediates Monocyte Activation by Listeria monocytogenes , But Not by Group B Streptococci or Lipopolysaccharide 2000 ·The Journal of Immunology ·Trude Helen Flo, Øyvind Halaas, Egil Lien, Liv Ryan, Giuseppe Teti, Douglas T. Golenbock, Anders Sundan, Terje Espevik	255
17	Apoptosis, proliferation and NF‐κB activation induced by agonistic Fas antibodies in the human myeloma cell line OH‐2: amplification of Fas‐mediated apoptosis by tumor necrosis factor 1999 ·European Journal Of Haematology ·Magne Børset, Henrik Hjorth‐Hansen, (unknown), Carina Seidel, Anders Waage, Terje Espevik, Anders Sundan	19
18	Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell Lines 1996 ·Journal of Biological Chemistry ·Magne Børset, Egil Lien, Terje Espevik, Eirik Helseth, Anders Waage, Anders Sundan	122
19	The Involvement of CD 14 in Stimulation of TNF Production from Peripheral Mononuclear Cells Isolated from PNH Patients† 1995 ·Scandinavian Journal of Immunology ·Anders Sundan, Liv Ryan, (unknown), Terje Espevik, Anders Waage	11
20	Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. 1990 ·The Journal of Experimental Medicine ·M R Shalaby, Anders Sundan, Hansruedi Loetscher, Manfred Brockhaus, Werner Lesslauer, Terje Espevik	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact